Post-COVID pandemic, discussions on the immune system and recovery mechanisms have escalated beyond simple disease control to become core issues in biological health design.
Especially for those sustaining high-intensity training or using specific bio-strategies, regulating the timing and efficiency of immune responses has become critical.
This article analyzes the points we must address, caught between past scientific consensus and recently revealed data.
In the early days of COVID, Dr. Anthony Fauci, then-director of the NIAID, strongly recommended vaccination even for children aged 5-11 and advised vaccination even for children with a history of infection.
This was a decision based on the premise that vaccine-induced immunity is superior to natural immunity.
Following this tone, the CDC (U.S. Centers for Disease Control and Prevention) granted emergency authorization for mRNA vaccines for children from 6 months to 11 years old, and indiscriminate vaccinations were carried out across the U.S.
However, as of 2025, the situation has rapidly changed.
The FDA, in an official document (released March 2025), restricted the use of the Novavax vaccine to those 65 and older or high-risk groups, and similar policy realignments are underway for the Moderna and Pfizer vaccines.
This is a complete reversal from the initial mass vaccination policy.
The bigger shock is the re-examination of the virus’s origins.
In late 2024, the U.S. White House officially stated that ‘COVID-19 is highly likely a manipulated virus leaked from a lab in Wuhan, China.’
This directly conflicts with the natural origin theory long advocated by Dr. Fauci.
Furthermore, allegations have arisen that U.S. health authorities’ funding was used for Gain of Function research (experiments that artificially enhance a virus’s infectivity or lethality) at the Wuhan Institute of Virology.
[U.S. White House Website Link]
https://www.whitehouse.gov/lab-leak-true-origins-of-covid-19/
A high-ranking official from the NIH (National Institutes of Health) has admitted during a congressional hearing that the funding was provided, and state-level investigations are currently underway.
Doubts are growing as to whether this entire sequence of events was truly based on pure scientific judgment.
This is why analyses are emerging that suggest certain decisions may have been orchestrated based on political signals or industrial interests.
In fact, many experts are voicing opinions that vaccines were not the only answer, and arguments continue that “drug repurposing”—finding new uses for existing drugs—was a much more practical strategy.
A prime example is Pyramax.
This drug was used as a malaria treatment, but in 2020, antiviral effects against COVID were observed in some clinical trials both domestically and internationally.
However, health authorities at the time dismissed the discussion, framing it as “unscientific agitation” rather than re-evaluating the data.
This can be criticized as a judgment based on atmosphere rather than science, especially when compared to the case of AZT (originally developed as a cancer drug) which was repurposed as an HIV treatment.
The more critical issue is the physiological understanding of the immune response itself.
While mRNA vaccines induce a strong immune response, research findings have been published showing they can cause severe side effects in individuals with specific genetic sensitivities, such as mitochondrial dysfunction, T-cell disruption, and myocarditis.
(Cell Reports Medicine, 2023)
These reactions can have a significant impact, especially on those with high training intensity or those who are finely tuning their immune system and recovery cycles.
Ultimately, what is needed now is not binary thinking.
Instead of unconditionally supporting or opposing vaccines, a flexible approach based on physiological data and practical recovery strategies is necessary.
The integrated design of drug repurposing, basal immune modulation, and precise calibration of recovery timing is no longer an option but a necessity for advanced bodybuilders.
Lastly, the critical point is the attitude toward information.
Health strategies should no longer be designed based on the political climate or trends.
What is needed now is a strictly data-driven strategy and scientific flexibility.
Immunity and recovery are not just medical issues; they are the core of biological design.
Moving forward, we must choose fact- and data-centric thinking over an attitude of following without question.
